$TNXP News Article - Tonix Pharmaceuticals and Massachusetts General Hospital Enter into Research Collaboration to Develop Tonix's Third Generation Anti-CD154 Monoclonal Antibody, TNX-1500, for the Treatment and Prevention of Organ Transplant Rejection https://marketwirenews.com/news-releases/toni...20189.html